Ryan Nelson
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research 3
- Cancer Research top 1%
- Epidemiology top 2%
- Hepatology top 5%
-
- Health Systems, Economic Evaluations, Quality of Life 2
- Economic and Financial Impacts of Cancer 1
-
- RNA Interference and Gene Delivery 2
-
- Blood Pressure and Hypertension Studies 1
-
- HIV/AIDS Research and Interventions 1
-
- Tissue Engineering and Regenerative Medicine 1
-
- Immunotherapy and Immune Responses 1
- Co-authors
- John Sahl AndersenMalcolm J. MooreRussell K. PortenoyHoward A. BurrisManuel ModianoF. Andrew DorrM. Christine CrippsMace L. Rothenberg
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Ryan Nelson
9 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 3.9k
- Cancer Research 1.4k
- Pulmonary and Respiratory Medicine 1.1k
- Epidemiology 1.1k
- Hepatology 202
Countries citing papers authored by Ryan Nelson
This map shows the geographic impact of Ryan Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Nelson more than expected).
Fields of papers citing papers by Ryan Nelson
This network shows the impact of papers produced by Ryan Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Nelson. The network helps show where Ryan Nelson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ryan Nelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 16 | |
| 2 | 2023 | 11 | |
| 3 | 2023 | 7 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 2 | |
| 6 | 2015 | 1 | |
| 7 | 2011 | 31 | |
| 8 | 2011 | 11 | |
| 9 | Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.breakdown → | 1997 | 4630 |
About Ryan Nelson
Ryan Nelson is a scholar working on Family Practice, Biophysics, Oncology, Statistics and Probability and Orthopedics and Sports Medicine, having authored 9 papers that have together received 4.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), RNA Interference and Gene Delivery (2 papers), Blood Pressure and Hypertension Studies (1 paper), HIV/AIDS Research and Interventions (1 paper), Tissue Engineering and Regenerative Medicine (1 paper), Immunotherapy and Immune Responses (1 paper) and Economic and Financial Impacts of Cancer (1 paper). The work is most often cited by research in Oncology (3.9k citations), Cancer Research (1.4k citations), Pulmonary and Respiratory Medicine (1.1k citations), Epidemiology (1.1k citations) and Hepatology (202 citations). Ryan Nelson has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include John Sahl Andersen, Malcolm J. Moore, Russell K. Portenoy, Howard A. Burris, Manuel Modiano, F. Andrew Dorr, M. Christine Cripps, Mace L. Rothenberg, Peter G. Tarassoff and Connie Stephens. Their work appears in journals such as Journal of Clinical Oncology, Value in Health, Pharmaceutics, Oncogene and Heart.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.